Successful treatment after toxic epidermal necrolysis induced by AZD-9291 in a patient with non-small cell lung cancer: A case report

BACKGROUND: Toxic epidermal necrolysis and Stevens-Johnson syndrome are acute life-threatening skin reactions. AZD9291 has been developed as a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) with activity against T790M mutation. CASE SUMMARY: Herein we report...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wen, He, Xiang, Liu, Hui, Zhu, Jiong, Zhang, Hui-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546833/
https://www.ncbi.nlm.nih.gov/pubmed/34734065
http://dx.doi.org/10.12998/wjcc.v9.i29.8846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546833/
https://www.ncbi.nlm.nih.gov/pubmed/34734065
http://dx.doi.org/10.12998/wjcc.v9.i29.8846

Ejemplares similares